363 related articles for article (PubMed ID: 11810779)
21. [Comparison of treatment efficacy of the second and the third generations of chemoradiotherapy regimens containing platinum on advanced non-small cell lung cancer].
Wang YM; Guo LJ; Li LS; Li P; Zheng J; Li L
Ai Zheng; 2005 Dec; 24(12):1514-7. PubMed ID: 16351804
[TBL] [Abstract][Full Text] [Related]
22. Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer.
Belani CP; Wang W; Johnson DH; Wagner H; Schiller J; Veeder M; Mehta M;
J Clin Oncol; 2005 Jun; 23(16):3760-7. PubMed ID: 15837967
[TBL] [Abstract][Full Text] [Related]
23. Double-flash, large-fraction radiation therapy as palliative treatment of malignant superior vena cava syndrome in the elderly.
Lonardi F; Gioga G; Agus G; Coeli M; Campostrini F
Support Care Cancer; 2002 Mar; 10(2):156-60. PubMed ID: 11862505
[TBL] [Abstract][Full Text] [Related]
24. Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer.
Bellière A; Girard N; Chapet O; Khodri M; Kubas A; Souquet PJ; Mornex F
Cancer Radiother; 2009 Jul; 13(4):298-304. PubMed ID: 19525134
[TBL] [Abstract][Full Text] [Related]
25. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
[TBL] [Abstract][Full Text] [Related]
26. Gender difference in treatment outcomes in patients with stage III non-small cell lung cancer receiving concurrent chemoradiotherapy.
Sekine I; Sumi M; Ito Y; Tanai C; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
Jpn J Clin Oncol; 2009 Nov; 39(11):707-12. PubMed ID: 19692418
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of combined radiation, paclitaxel and carboplatin for locally advanced non-small cell lung carcinoma.
Nguyen NP; Leonardo JM; Karlsson U; Vos P; Bullock L; Thomas P; Lepera P; Ludin A; Chu C; Salehpour M; Jendrasiak G; Sallah S
Anticancer Res; 2002; 22(6B):3429-35. PubMed ID: 12552935
[TBL] [Abstract][Full Text] [Related]
28. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
Rusu P; Ciuleanu TE; Cernea D; Pelau D; Gaal V; Cebotaru C; Guttman T; Todor N; Ghilezan N
J BUON; 2007; 12(1):33-9. PubMed ID: 17436399
[TBL] [Abstract][Full Text] [Related]
29. [The superior vena cava syndrome as an emergency in radiotherapy].
Beck C; Berberich W; Bauknecht A; Schnabel K
Strahlenther Onkol; 1990 Dec; 166(12):798-802. PubMed ID: 2176355
[TBL] [Abstract][Full Text] [Related]
30. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
Huang GJ; Fang DK; Cheng GY; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
[TBL] [Abstract][Full Text] [Related]
31. Influence of smoking on histologic type and the efficacy of adjuvant chemotherapy in resected non-small cell lung cancer.
Zhang Z; Xu F; Wang S; Li N; Wang C
Lung Cancer; 2008 Jun; 60(3):434-40. PubMed ID: 18036699
[TBL] [Abstract][Full Text] [Related]
32. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.
Komaki R; Lee JS; Milas L; Lee HK; Fossella FV; Herbst RS; Allen PK; Liao Z; Stevens CW; Lu C; Zinner RG; Papadimitrakopoulou VA; Kies MS; Blumenschein GR; Pisters KM; Glisson BS; Kurie J; Kaplan B; Garza VP; Mooring D; Tucker SL; Cox JD
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1369-77. PubMed ID: 15050312
[TBL] [Abstract][Full Text] [Related]
33. A phase II study of hyperfractionated accelerated radiotherapy (HART) after induction cisplatin (CDDP) and vinorelbine (VNR) for stage III non-small-cell lung cancer (NSCLC).
Ishikura S; Ohe Y; Nihei K; Kubota K; Kakinuma R; Ohmatsu H; Goto K; Niho S; Nishiwaki Y; Ogino T
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1117-22. PubMed ID: 15752891
[TBL] [Abstract][Full Text] [Related]
34. The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer.
Hirose T; Mizutani Y; Ohmori T; Ishida H; Hosaka T; Ando K; Shirai T; Okuda K; Ohnishi T; Horichi N; Kubota H; Adachi M
Cancer Chemother Pharmacol; 2006 Sep; 58(3):361-7. PubMed ID: 16331494
[TBL] [Abstract][Full Text] [Related]
35. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
Cho KH; Ahn SJ; Pyo HR; Kim KS; Kim YC; Moon SH; Han JY; Kim HT; Koom WS; Lee JS
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1397-404. PubMed ID: 19117690
[TBL] [Abstract][Full Text] [Related]
36. High-dose radiation therapy for inoperable non-small cell lung cancer without mediastinal involvement (clinical stage N0, N1).
Hayakawa K; Mitsuhashi N; Furuta M; Saito Y; Nakayama Y; Katano S; Yamakawa M; Hashida I; Niibe
Strahlenther Onkol; 1996 Sep; 172(9):489-95. PubMed ID: 8830811
[TBL] [Abstract][Full Text] [Related]
37. Vascular stenting for palliation of superior vena cava obstruction in non-small-cell lung cancer patients: a future 'standard' procedure?
Greillier L; Barlési F; Doddoli C; Durieux O; Torre JP; Gimenez C; Kleisbauer JP
Respiration; 2004; 71(2):178-83. PubMed ID: 15031575
[TBL] [Abstract][Full Text] [Related]
38. Study of superior vena cava syndrome--aetiopathology, diagnosis and management.
Tayade BO; Salvi SS; Agarwal IR
J Assoc Physicians India; 1994 Aug; 42(8):609-11. PubMed ID: 7868553
[TBL] [Abstract][Full Text] [Related]
39. [Gianturco expandable metallic stents in the treatment of superior vena cava syndrome caused by lung cancer].
Morita R; Akaogi E; Mitsui K; Kuramoto K; Onizuka M; Ishikawa S
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jun; 30(6):1110-5. PubMed ID: 1324377
[TBL] [Abstract][Full Text] [Related]
40. [Interventional therapy for lung cancer patients with superior vena cava syndrome].
Luo J; Chen B; Jiang S; Zhou SW
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):627-31. PubMed ID: 24314224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]